Status: Active


  • Status Current
  • Sector Structural Heart
  • Year Invested 2022
  • HQ Ascheim (Munich), Germany
  • Clinical Operations Germany, France, Belgium, Canada
  • Lead Partners Frederik Groenewegen


Related News

Transcatheter Tricuspid Valve Replacement Technology

Tricares developed Topaz, an innovative device developed to help patients suffering from severe tricuspid regurgitation without the need for open heart surgery. The Topaz device is implanted in a minimally invasive procedure through the patient’s femoral vein. It is designed specifically to fit the tricuspid valve anatomy and thus supports ease of positioning and functionality.